Hong Kong Biotech Stock News

Melco International Development’s earnings turnaround Melco International Development (SEHK:200) has moved back into the black, reporting full year 2025 net income of HK$1,058.31 million on sales of HK$40,240.89 million after a loss the previous year. See our latest analysis for Melco International Development. The earnings return has arrived alongside a 10.82% 7 day share price return and a 5.26% 30 day share price return. However, the 90 day share price return of a 2.33% decline and the 3...

Why China Youran Dairy Group’s latest circular delay and earnings matter for investors China Youran Dairy Group (SEHK:9858) has drawn attention after further delaying its circular on a connected share subscription and whitewash waiver, while also reporting full year 2025 results that included CNY 20,653.71 million in sales and a narrowed net loss. See our latest analysis for China Youran Dairy Group. At a share price of HK$4.21, the stock has a 1 day share price return of 5.78% and 7 day...

Earnings and dividend move put Ruifeng Power Group in focus Ruifeng Power Group (SEHK:2025) has drawn investor attention after reporting full year 2025 results together with a proposed increase in its final dividend, combining earnings information with a clearer signal on shareholder payouts. For the year ended 31 December 2025, Ruifeng Power Group reported sales of CN¥1,109.4 million and net income of CN¥23.27 million, with basic earnings per share from continuing operations of CN¥0.029. See...

Chery Automobile: Recent Price Moves Catch Investor Attention Chery Automobile (SEHK:9973) has drawn fresh attention after a recent share price move, with the stock showing positive returns over the past week, month, and past 3 months. See our latest analysis for Chery Automobile. The recent 1 day share price return of 15.26% at HK$32.02 caps a period of building momentum, with short term moves outpacing the 6.03% year to date share price return. This is shifting attention back to how the...

What GCL Technology Holdings' Latest Earnings Mean For Investors GCL Technology Holdings (SEHK:3800) released full year 2025 results, reporting sales of CN¥14,424.93 million compared with CN¥15,097.56 million a year earlier, and a narrowed net loss of CN¥2,867.89 million. See our latest analysis for GCL Technology Holdings. The latest results arrived after a period where the share price has been under pressure, with a 30 day share price return of an 11.32% decline and a 90 day share price...

Earnings turnaround puts Oshidori International Holdings (SEHK:622) in focus Oshidori International Holdings (SEHK:622) has caught investor attention after reporting full year 2025 earnings, shifting from a net loss to net income of HK$179.05 million with positive basic and diluted earnings per share. See our latest analysis for Oshidori International Holdings. At a share price of HK$1.73, Oshidori International Holdings has seen a 130.67% year to date share price return, while its 1 year...

China Resources Mixc Lifestyle Services (SEHK:1209) has drawn fresh attention after reporting full year 2025 results, with sales of CN¥18,021.62 million and net income of CN¥3,969.02 million from continuing operations. See our latest analysis for China Resources Mixc Lifestyle Services. The earnings release comes after a strong run, with a 7 day share price return of 5.54% and a year to date share price return of 8.78%. The 1 year total shareholder return of 40.12% points to momentum that has...

Why Luye Pharma’s latest earnings matter for investors Luye Pharma Group (SEHK:2186) has drawn fresh attention after reporting its full year 2025 results, with higher sales and net income alongside a decision not to declare a 2025 dividend. The company reported sales of CN¥6,308.37 million for 2025, compared with CN¥6,061.44 million a year earlier. Net income came in at CN¥618.75 million, up from CN¥471.89 million, while basic earnings per share from continuing operations were CN¥0.1588...

CGN Power (SEHK:1816) just reported full year 2025 results showing lower revenue and net income, alongside a proposed smaller final dividend of RMB 0.086 per share. This is putting income expectations and valuation under closer scrutiny for investors. See our latest analysis for CGN Power. The earnings and dividend announcement comes after a period of strong gains for investors, with a 30 day share price return of 12.46% and a 1 year total shareholder return of 43.16%. However, the 7 day...

Zhejiang Expressway (SEHK:576) has released new figures for its 2025 full year earnings, together with a proposed dividend increase. This combination gives income focused investors new information to assess. See our latest analysis for Zhejiang Expressway. At a share price of HK$7.45, Zhejiang Expressway has seen a 1 month share price return of 7.97%, while its 1 year total shareholder return of 21.27% and 3 year total shareholder return of 53.43% point to momentum that has built over time...

What the latest earnings and drug news mean for Hansoh Pharmaceutical Group The latest move in Hansoh Pharmaceutical Group (SEHK:3692) is being shaped by two fresh developments: full year 2025 earnings and new regulatory progress for its autoimmune drug XINYUE in China. For the year ended 31 December 2025, Hansoh Pharmaceutical Group reported sales of CN¥15,028.32 million, compared with CN¥12,260.81 million a year earlier, and net income of CN¥5,555.46 million versus CN¥4,371.83...

What the latest earnings and dividend move mean for Shougang Fushan Resources Group (SEHK:639) Shougang Fushan Resources Group (SEHK:639) has drawn attention after reporting full year 2025 results showing lower net income and earnings per share, alongside a proposed final dividend of HK$0.06 per share. This combination of reduced profitability and a smaller final payout raises straightforward questions for you as a shareholder, especially around income expectations, payout sustainability, and...

China Longyuan Power Group (SEHK:916) has released its full year 2025 results, reporting sales of CN¥30,252.71 million and net income of CN¥4,526.22 million, both lower than the previous year. See our latest analysis for China Longyuan Power Group. The stock has been under pressure in the past month, with an 8.69% 30 day share price return and a 9.04% 7 day share price return, although the 1 year total shareholder return of 14.31% contrasts with weaker 3 and 5 year total shareholder...

Assessing Semiconductor Manufacturing International after recent share price weakness Semiconductor Manufacturing International (SEHK:981) has come under pressure recently, with the share price showing a 3.5% decline over the past day and a 16.7% drop over the past month. For investors, this invites a fresh look at how the current valuation aligns with the company’s scale and earnings profile. See our latest analysis for Semiconductor Manufacturing International. At the current share price of...

Marketingforce Management (SEHK:2556) just posted full year 2025 earnings that shifted from a CNY 876.67 million net loss a year earlier to a CNY 88.94 million net profit, alongside higher reported sales and positive earnings per share. See our latest analysis for Marketingforce Management. Despite the swing back to profit, the recent share price performance has been weak. The 7 day share price return is 10.88% and the year to date share price return is 14.68%, while the 1 year total...

How BYD’s Recent Performance Sets the Stage for Investor Questions With no single headline event in play, BYD (SEHK:1211) has still drawn attention after a recent share price move, including a roughly 9% gain over the past month and a modest rise over the past 3 months. See our latest analysis for BYD. At the current share price of HK$103.9, BYD’s recent 1 month share price return of 9.31% and 3 month share price return of 5.22% sit against a 1 year total shareholder return decline of 15.92%...

CALB Group (SEHK:3931) has just released its full year 2025 results, reporting sales of CN¥44,400.07 million and net income of CN¥1,475.63 million. These figures may influence how you assess the stock. See our latest analysis for CALB Group. The earnings release appears to sit alongside strong recent momentum, with a 30 day share price return of 29.11% and a 1 year total shareholder return of 86.44%. Meanwhile, the 3 year total shareholder return of 71.16% suggests earlier gains were more...

Zhongsheng Group Holdings (SEHK:881) released its full year 2025 results, reporting sales of CNY 164,403.43 million and a net loss of CNY 1,673.29 million. The company also announced a decision to skip the final dividend. See our latest analysis for Zhongsheng Group Holdings. The weak 30 day share price return of 11.09% and 90 day share price return of 27.04% point to fading momentum, and the 1 year total shareholder return of 33.28% underlines how pressure has built over time despite the...

Why Brilliance China Automotive’s latest earnings matter for shareholders Brilliance China Automotive Holdings (SEHK:1114) has just released full year 2025 results, reporting CNY 1,181.92 million in sales and CNY 1,985.69 million in net income, with earnings per share lower than in the prior year. See our latest analysis for Brilliance China Automotive Holdings. Brilliance China Automotive’s share price has pulled back recently, with a 30 day share price return showing a decline of 23.65% and...

China Overseas Property Holdings (SEHK:2669) has just released its full year 2025 results along with a proposed ordinary final dividend of HK$0.10 per share, giving investors fresh information on both operations and cash returns. See our latest analysis for China Overseas Property Holdings. At a share price of HK$4.03, the stock has a 90 day share price return of a 12.01% decline and a 1 year total shareholder return of a 23.35% decline, pointing to fading momentum despite the latest earnings...

Investors were disappointed with the weak earnings posted by Yuexiu Transport Infrastructure Limited ( HKG:1052...

After announcing healthy earnings, RemeGen Co., Ltd.'s ( HKG:9995 ) stock rose over the last week. Despite the strong...

Qyuns Therapeutics Co., Ltd. ( HKG:2509 ) just reported healthy earnings but the stock price didn't move much. We think...

YesAsia Holdings Limited's ( HKG:2209 ) robust recent earnings didn't do much to move the stock. We believe that...